We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+13.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.71B
AUM Growth
+$351M
Cap. Flow
-$22.1M
Cap. Flow %
-0.6%
Top 10 Hldgs %
21.85%
Holding
5,705
New
584
Increased
2,919
Reduced
1,681
Closed
462

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$206M
2
META icon
Meta Platforms (Facebook)
META
+$37.5M
3
AMZN icon
Amazon
AMZN
+$35.5M
4
AVGO icon
Broadcom
AVGO
+$34.8M
5
MSFT icon
Microsoft
MSFT
+$29.8M

Sector Composition

Rank Sector Weight
1 Technology 20.47%
2 Financials 11.61%
3 Healthcare 8.42%
4 Industrials 6.72%
5 Consumer Discretionary 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLN
3851
Silence Therapeutics
SLN
$695M
$14.1K ﹤0.01%
2,428
+61
+3% +$262
RNG icon
3852
RingCentral
RNG
$5.3B
$14K ﹤0.01%
495
-191
-28% -$4.93K
DUOT icon
3853
Duos Technologies
DUOT
$275M
$13.9K ﹤0.01%
+1,950
New +$13.4K
HOLO icon
3854
MicroCloud Hologram
HOLO
$39M
$13.9K ﹤0.01%
+2,845
New +$29.6K
GAIN icon
3855
Gladstone Investment Corp
GAIN
$655M
$13.9K ﹤0.01%
971
-2,985
-75% -$41.7K
SN icon
3856
SharkNinja
SN
$26.4B
$13.7K ﹤0.01%
138
-4,973
-97% -$430K
BIOA
3857
BioAge Labs
BIOA
$490M
$13.7K ﹤0.01%
3,305
+901
+37% +$3.63K
PRLD icon
3858
Prelude Therapeutics
PRLD
$424M
$13.6K ﹤0.01%
16,799
+3,213
+24% +$2.78K
RZLT icon
3859
Rezolute
RZLT
$445M
$13.6K ﹤0.01%
+3,048
New +$11.3K
SATL icon
3860
Satellogic
SATL
$884M
$13.5K ﹤0.01%
3,735
+3,716
+19,558% +$14K
IMDX
3861
Insight Molecular Diagnostics
IMDX
$143M
$13.5K ﹤0.01%
4,468
+3,304
+284% +$9.98K
TARA icon
3862
Protara Therapeutics
TARA
$220M
$13.4K ﹤0.01%
4,434
+4,287
+2,916% +$14.8K
ETH
3863
Grayscale Ethereum Staking Mini ETF Shares
ETH
$1.72B
$13.4K ﹤0.01%
+566
New +$11.7K
STTK icon
3864
Shattuck Labs
STTK
$686M
$13.4K ﹤0.01%
16,886
+8,454
+100% +$8.2K
GOCO
3865
DELISTED
GoHealth
GOCO
$13.3K ﹤0.01%
2,404
+1,002
+71% +$7.92K
IPO icon
3866
Renaissance IPO ETF
IPO
$159M
$13.3K ﹤0.01%
296
-29,639
-99% -$1.21M
LYRA
3867
DELISTED
LYRA THERAPEUTICS INC
LYRA
$13.3K ﹤0.01%
1,483
+428
+41% +$3.55K
YANG icon
3868
Direxion Daily FTSE China Bear 3X ETF
YANG
$92.9M
$13.3K ﹤0.01%
433
-243
-36% -$9.34K
ATHR
3869
Aether Holdings
ATHR
$46M
$13.2K ﹤0.01%
+971
New +$11.1K
OTLK icon
3870
Outlook Therapeutics
OTLK
$211M
$13.2K ﹤0.01%
8,259
-399
-5% -$636
DVLT
3871
Datavault AI
DVLT
$262M
$13.2K ﹤0.01%
+19,918
New +$15.4K
SRG
3872
Seritage Growth Properties
SRG
$135M
$13.2K ﹤0.01%
+4,271
New +$12.3K
CCC
3873
CCC Intelligent Solutions
CCC
$4.05B
$13.1K ﹤0.01%
1,397
-4,576
-77% -$40.9K
NGG icon
3874
National Grid
NGG
$80.7B
$13.1K ﹤0.01%
179
-278
-61% -$19.1K
RZLV
3875
Rezolve AI
RZLV
$1.11B
$13.1K ﹤0.01%
4,256
+3,281
+337% +$6.46K

Similar funds

Tower Research Capital (TRC)'s Q2 2025 Portfolio in Review

As of Q2 2025, Tower Research Capital (TRC) held 5,705 positions worth $3.71B, up 10% from $3.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Tower Research Capital (TRC)'s Q2 2025 filing shows 584 new, 2,919 increased, 1,681 reduced and 462 closed positions. Its largest new stake was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M. The largest sale was Invesco QQQ Trust, an estimated $206M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Tower Research Capital (TRC)'s largest Q2 2025 buy was State Street SPDR Bloomberg 1-3 Month T-Bill ETF: 218,270 shares worth $20M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2025, an estimated $127M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2025 reduction was Invesco QQQ Trust, cutting an estimated $206M.
  • Tower Research Capital (TRC) fully exited iShares S&P 500 Value ETF in Q2 2025, selling an estimated $6.43M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 22% of its $3.71B portfolio in Q2 2025.
  • Tower Research Capital (TRC) opened 584 new positions and closed 462 in Q2 2025.
  • Tower Research Capital (TRC)'s portfolio value rose 10% quarter-over-quarter to $3.71B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2025, filed 15 Aug 2025.